Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction

被引：0
|
作者：
Hasan Ali Barman
Selim Tanyolaç
Omer Dogan
Erdem Bal
Adem Atıcı
Serhan Özyıldırım
Zerrin Yiğit
机构：
[1] Istanbul University-Cerrahpaşa,Department of Cardiology, Institute of Cardiology
[2] Goztepe Training and Research Hospital,Department of Cardiology, Faculty of Medicine
[3] Istanbul Medeniyet University,undefined
来源：
Clinical Drug Investigation | 2022年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：533 / 540
页数：7
相关论文
共 50 条
  • [21] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [22] DIASTOLIC FUNCTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED BY SACUBITRIL/VALSARTAN
    Lamaida, N.
    Cerciello, A.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [23] The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension
    Yu Takigami
    Shunsuke Ishii
    Yuko Eda
    Mayu Yazaki
    Teppei Fujita
    Yuichiro Iida
    Yuki Ikeda
    Takeru Nabeta
    Jun Oikawa
    Toshimi Koitabashi
    Junya Ako
    [J]. Heart and Vessels, 2023, 38 : 1337 - 1343
  • [24] The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension
    Takigami, Yu
    Ishii, Shunsuke
    Eda, Yuko
    Yazaki, Mayu
    Fujita, Teppei
    Iida, Yuichiro
    Ikeda, Yuki
    Nabeta, Takeru
    Oikawa, Jun
    Koitabashi, Toshimi
    Ako, Junya
    [J]. HEART AND VESSELS, 2023, 38 (11) : 1337 - 1343
  • [25] Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction
    Ganesananthan, S.
    Shah, N.
    Shah, P.
    Phillips, J.
    Elsayed, H.
    Yousef, Z.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 222 - 222
  • [26] Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction
    Landolfo, Matteo
    Piani, Federica
    Esposti, Daniela Degli
    Cosentino, Eugenio
    Bacchelli, Stefano
    Dormi, Ada
    Borghi, Claudio
    [J]. IJC HEART & VASCULATURE, 2020, 31
  • [27] Effects of valsartan/sacubitril on parameters of ventricular-arterial coupling in patients with heart failure and reduced ejection fraction
    Kobalava, Z.
    Villevalde, S.
    Tyukhmenev, E.
    Lukina, O. Olga
    Babaeva, L.
    Zharikova, E.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 47 - 47
  • [28] Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction
    Cosentino, Eugenio Roberto
    Degli Esposti, Daniela
    Miceli, Rinaldo
    Bentivenga, Crescenzio
    Landolfo, Matteo
    Cicero, Arrigo F. G.
    Berardi, Emanuela
    Spinardi, Luca
    Magri, Gianluigi
    Dugato, Vittorio
    Borghi, Claudio
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 : 9 - 12
  • [29] Dose-dependent impact of sacubitril/valsartan on left ventricular ejection fraction and survival in patients with heart failure with reduced ejection fraction
    Furlan, T.
    Mihelcic, G.
    Leskovar, B.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 115 - 116
  • [30] Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Buonacera, Agata
    Stancanelli, Benedetta
    Malatino, Lorenzo
    [J]. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (04) : 331 - 332
12345